Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 10

Showing 10 citing articles:

Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing
Christof Wedemeyer, Martin Peters, Graham L. Jones
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round Table
Stefanie Dimmeler, Leticia Ferri, Paul Nioi, et al.
European Heart Journal (2025)
Closed Access
Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options
György Paragh, Péter Zilahi, László Róbert Kolozsvári, et al.
Life (2024) Vol. 14, Iss. 3, pp. 374-374
Open Access | Times Cited: 2
Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction
Jakub Michał Zimodro, Aleksandra Gąsecka, Piotr Arski, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 3, pp. 1043-1047
Open Access | Times Cited: 2
Association between elevated lipoprotein(a) levels and vulnerability of carotid atherosclerotic plaque: A systematic review.
Fernando Garagoli, Walter Masson, Leandro Barbagelata
Journal of Stroke and Cerebrovascular Diseases (2024), pp. 108020-108020
Closed Access | Times Cited: 1
Exploring the Interplay between Diabetes and Lp(a): Implications for Cardiovascular Risk
Corral Pablo, Arrupe Matías, Augusto Lavalle-Cobo, et al.
Current Diabetes Reports (2024) Vol. 24, Iss. 7, pp. 167-172
Closed Access | Times Cited: 1
The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report
Volker Schettler, N Selke, S Jenke, et al.
Atherosclerosis (2024) Vol. 398, pp. 118601-118601
Closed Access
Role of Lipoprotein(a) Reduction in Cardiovascular Disease
Uma Heidi Schuth, Kieran Gill, Pyotr Telyuk, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6311-6311
Open Access
Future Directions for Quantitative Systems Pharmacology
Birgit Schoeberl, Cynthia J. Musante, Saroja Ramanujan
Handbook of experimental pharmacology (2024)
Closed Access
Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials
Ikponmwosa Jude Ogieuhi, Kristen Callender, God-dowell O. Odukudu, et al.
High Blood Pressure & Cardiovascular Prevention (2024)
Closed Access
Page 1

Scroll to top